FI891144A0 - Förfarande för framställning av nya terapeutiskt användbara saltföreningar - Google Patents

Förfarande för framställning av nya terapeutiskt användbara saltföreningar

Info

Publication number
FI891144A0
FI891144A0 FI891144A FI891144A FI891144A0 FI 891144 A0 FI891144 A0 FI 891144A0 FI 891144 A FI891144 A FI 891144A FI 891144 A FI891144 A FI 891144A FI 891144 A0 FI891144 A0 FI 891144A0
Authority
FI
Finland
Prior art keywords
preparation
therapeutically useful
salt compounds
useful salt
novel therapeutically
Prior art date
Application number
FI891144A
Other languages
English (en)
Finnish (fi)
Other versions
FI93949C (sv
FI891144A (sv
FI93949B (sv
Inventor
Nagy Peter Literati
Maria Boros
Jenoe Szilbereky
Istvan Racz
Gyoengyver Soos
Miklos Koller
Alan Pinter
Gabor Nemeth
Original Assignee
Biorex Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kft filed Critical Biorex Kft
Publication of FI891144A0 publication Critical patent/FI891144A0/sv
Publication of FI891144A publication Critical patent/FI891144A/sv
Application granted granted Critical
Publication of FI93949B publication Critical patent/FI93949B/sv
Publication of FI93949C publication Critical patent/FI93949C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI891144A 1988-03-09 1989-03-09 Förfarande för framställning av nya terapeutiskt användbara saltföreningar FI93949C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU113188 1988-03-09
HU881131A HU199775B (en) 1988-03-09 1988-03-09 Process for production of formed by fatty acids salts of amin acids and medical compositions containing them

Publications (4)

Publication Number Publication Date
FI891144A0 true FI891144A0 (sv) 1989-03-09
FI891144A FI891144A (sv) 1989-09-10
FI93949B FI93949B (sv) 1995-03-15
FI93949C FI93949C (sv) 1995-06-26

Family

ID=10952971

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891144A FI93949C (sv) 1988-03-09 1989-03-09 Förfarande för framställning av nya terapeutiskt användbara saltföreningar

Country Status (16)

Country Link
JP (1) JP2751068B2 (sv)
KR (1) KR0140993B1 (sv)
AT (1) AT398073B (sv)
BE (1) BE1003663A3 (sv)
CA (1) CA1339147C (sv)
CH (1) CH678851A5 (sv)
DE (1) DE3907688C2 (sv)
ES (1) ES2010439A6 (sv)
FI (1) FI93949C (sv)
FR (1) FR2628419B1 (sv)
GB (1) GB2216522B (sv)
HU (1) HU199775B (sv)
IT (1) IT1229563B (sv)
LU (1) LU87470A1 (sv)
NL (1) NL8900573A (sv)
SE (1) SE508603C2 (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04279523A (ja) * 1991-01-11 1992-10-05 Nisshin Flour Milling Co Ltd 免疫賦活油脂加工品
DE69231592T2 (de) * 1991-06-24 2001-06-21 Women's And Children's Hospital, North Adelaide Verfahren und zusammensetzungen zur behandlung von malaria und anderen erkrankungen
WO1995009622A1 (en) * 1993-10-06 1995-04-13 Peptide Technology Limited Polyunsaturated fatty acids and uses thereof
NL9401743A (nl) * 1994-10-20 1996-06-03 Prospa Bv Zouten van aminoalcoholen en farmaceutische formuleringen die deze bevatten.
AUPM906594A0 (en) * 1994-10-26 1994-11-17 Peptide Technology Limited Synthetic polyunsaturated fatty acid analogues
US5639858A (en) * 1995-03-22 1997-06-17 Tularik, Inc. Human signal transducer and binding assays
HU227588B1 (hu) * 2004-12-03 2011-09-28 Sinnex Mueszaki Fejlesztoe Es Tanacsado Kft Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény
NZ569535A (en) 2005-12-30 2011-12-22 Revance Therapeutics Inc Arginine heteromers for topical administration
JP6861156B2 (ja) 2014-12-23 2021-04-21 エボニック オペレーションズ ゲーエムベーハー ω−３系多価不飽和脂肪酸を含む組成物の安定性を向上させる方法
EP3248467A1 (de) 2016-05-25 2017-11-29 Evonik Technochemie GmbH Verfahren zur herstellung einer zusammensetzung enthaltend omega-3-fettsäure-l-lysin-salze
CA3072658C (en) * 2017-08-15 2023-01-24 Evonik Operations Gmbh Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
JP2023514506A (ja) * 2020-01-30 2023-04-06 シリサイクル インコーポレイティド 多価不飽和脂肪酸の固体中性アミノ酸塩の製造プロセス

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4887011A (sv) * 1972-02-04 1973-11-16
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
GB8327911D0 (en) * 1983-10-19 1983-11-23 Ciba Geigy Ag Salts as corrosion inhibitors
US4537772A (en) * 1984-05-02 1985-08-27 Merck & Co., Inc. Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines
FR2587900B1 (fr) * 1985-10-01 1988-10-07 Morelle Jean Associations acides gras-acides amines basiques, douees de proprietes emollientes, emulsifiantes et antioxydantes, destinees a la cosmetique, la dermatologie et l'alimentation
JPS63230632A (ja) * 1987-03-20 1988-09-27 Nippon Oil & Fats Co Ltd リポキシゲナ−ゼ代謝刺激剤
DE3726299A1 (de) * 1987-06-26 1989-02-23 Dietl Hans Fettemulsion zur intravenoesen anwendung

Also Published As

Publication number Publication date
GB8905384D0 (en) 1989-04-19
CA1339147C (en) 1997-07-29
SE8900827D0 (sv) 1989-03-09
FI93949C (sv) 1995-06-26
BE1003663A3 (fr) 1992-05-19
IT1229563B (it) 1991-09-04
FR2628419A1 (fr) 1989-09-15
KR890014451A (ko) 1989-10-23
CH678851A5 (sv) 1991-11-15
LU87470A1 (fr) 1990-10-02
GB2216522A (en) 1989-10-11
NL8900573A (nl) 1989-10-02
SE8900827L (sv) 1989-09-10
AT398073B (de) 1994-09-26
HU199775B (en) 1990-03-28
ES2010439A6 (es) 1989-11-01
FR2628419B1 (fr) 1992-02-14
FI891144A (sv) 1989-09-10
SE508603C2 (sv) 1998-10-19
ATA50989A (de) 1994-01-15
JP2751068B2 (ja) 1998-05-18
DE3907688A1 (de) 1989-09-21
DE3907688C2 (de) 1996-09-05
KR0140993B1 (ko) 1998-07-01
GB2216522B (en) 1992-01-02
JPH024746A (ja) 1990-01-09
FI93949B (sv) 1995-03-15
IT8919705A0 (it) 1989-03-09
HUT49564A (en) 1989-10-30

Similar Documents

Publication Publication Date Title
FI883064A0 (sv) Förfarande för framställning av terapeutiskt användbara heterocykliska föreningar
FI95704B (sv) Förfarande för framställning av nya terapeutiskt användbara pyridinderivat
FI92934B (sv) Analogiförfarande för framställning av terapeutiskt användbara 1-deoxinojirimycinderivat
FI892881A0 (sv) Förfarande för framställning av terapeutiskt användbara aminosyraderivat
FI880941A0 (sv) Förfarande för framställning av terapeutiskt användbara piperazinyl-heterocykliska föreningar
FI890282A (sv) Förfarande för framställning av terapeutiskt användbara 23,24-didehydro-25-hydroxikalciferolderivat
FI90769C (sv) Förfarande för framställning av terapeutiskt användbara triazolföreningar
FI874459A0 (sv) Förfarande för framställning av terapeutiskt användbara piperidinderivat
FI94752C (sv) Förfarande för framställning av terapeutiskt användbara propenonoximetrar
FI881303A0 (sv) Förfarande för framställning av ibuprofen
FI93215C (sv) Förfarande för framställning av terapeutiskt användbara aminoalkoxifenylderivat
FI880467A (sv) Förfarande för framställning av terapeutiskt användbara substituerade 3,4-dihydro-2H-benzopyraner
FI884910A (sv) Förfarande för framställning av terapeutiskt användbart bensopyranderivat
FI891144A0 (sv) Förfarande för framställning av nya terapeutiskt användbara saltföreningar
FI104171B1 (sv) Förfarande för framställning av mono-N-alkylerade polyazamakrocykliska föreningar
FI884471A0 (sv) Förfarande för framställning av terapeutiskt aktiva dihydropyridinföreningar
FI893003A0 (sv) Förfarande för framställning av terapeutiskt användbara neplanocinderivat
FI902316A0 (sv) Förfarande för framställning av terapeutiskt verkande substituerade dihydropyrrolizinföreningar
FI93119B (sv) Förfarande för framställning av nya tieno-triazolo-diatzepiner
FI98461B (sv) Förfarande för framställning av terapeutiskt användbara föreningar
FI886066A (sv) Förfarande för framställning av nya terapeutiskt användbara substituerade styrenderivat
FI94351B (sv) Förfarande för framställning av terapeutiskt användbara peptidderivater
FI911701A (sv) Förfarande för framställning av terapeutiskt användbara 2-substituerade-3-karboxikarbapenemer
FI92188C (sv) Förfarande för framställning av terapeutiskt användbara fenoxialkylpyrokatekolderivat
FI893434A0 (sv) Förfarande för framställning av nya terapeutiskt användbara cykloalkyltiazolderivat

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: BIOREX KFT